SleepCheckRx is an at-home test that ... test for COVID-19. ResApp also reported this week that Switzerland-headquartered telehealth provider Medgate has agreed to a 12-month extension to its ...

As the coronavirus pandemic convulsed the economy ... on pause — they won’t be considered delinquent — but that extension is nearly certain to end sometime this year. No one knows exactly ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Prasad is the latest in a series of medical contrarians and critics of COVID-19 measures to join the federal government under President Donald Trump. Unlike political roles such as FDA ...

The head of the U.S. Food and Drug Administration (FDA) reiterated Tuesday that the agency is applying a more skeptical approach to this year's round of COVID-19 vaccine boosters. Companies ...

The FDA has long defended this practice as a way of accelerating approval of medicines for desperately ill patients. During the COVID-19 pandemic, Prasad reached a much broader audience as a ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Because the coronavirus continually mutates, manufacturers follow instructions from FDA to make one change each year to their recipe — which strain to target — just like flu vaccines.

The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s ...